Guiding effective decisions: an interview with Matthew Segall, CEO of Optibrium Wendy A. Warr Warr’s Piece 12 January 2011 Pages: 103 - 106
Pharmacophore-driven identification of PPARγ agonists from natural sources Rasmus K. PetersenKathrine B. ChristensenIrene Kouskoumvekaki OriginalPaper 11 November 2010 Pages: 107 - 116
Catalytic residues in hydrolases: analysis of methods designed for ligand-binding site prediction Katarzyna PrymulaTomasz JadczykIrena Roterman OriginalPaper Open access 21 November 2010 Pages: 117 - 133
Quantitative structure–activity relationship analysis of β-amyloid aggregation inhibitors Shiri StemplerMichal Levy-SakinHanoch Senderowitz OriginalPaper 17 December 2010 Pages: 135 - 144
DFT calculation of four new potential agents muscarinic of bispyridinium type: structure, synthesis, biological activity, hydration, and relations with the potents W84 and DUO-3O M. Alcolea PalafoxP. Posada-MorenoI. Zaragoza-García OriginalPaper 22 December 2010 Pages: 145 - 161
Interaction of clozapine and its nitrenium ion with rat D2 dopamine receptors: in vitro binding and computational study Sébastien DillyJean-François Liégeois OriginalPaper 24 December 2010 Pages: 163 - 169
The molecular mechanism studies of chirality effect of PHA-739358 on Aurora kinase A by molecular dynamics simulation and free energy calculations Yuanhua ChengWei CuiFushi Zhang OriginalPaper 11 January 2011 Pages: 171 - 180
Structural-dynamical investigation of the ZnuA histidine-rich loop: involvement in zinc management and transport Mattia FalconiFrancesco OteriAlessandro Desideri OriginalPaper 15 January 2011 Pages: 181 - 194